Skip to content

Company information lookup

BIONOMICS LIMITED (BNO)

Developer of innovative treatments for cancer and diseases of the central nervous system.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BNO 0.450 -3.23% 0.450 0.470 0.465 0.470 0.450 119,820

BIONOMICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BNO
Securities
Official Listing Date 21 December, 1999
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.bionomics.com.au
Registered Office Address 31 Dalgleish Street, THEBARTON, SA, AUSTRALIA, 5031
Head Office Telephone 08 8354 6100
Head Office Fax 08 8354 6199
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 5, 115 GRENFELL STREET, ADELAIDE, SA, AUSTRALIA, 5000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Graeme Kaufman (Chairman)
Dr Deborah Rathjen (Managing Director, CEO)
Dr Errol De Souza (Non Exec. Director)
Dr Jonathan Lim (Non Exec. Director)
Mr Trevor Tappenden (Non Exec. Director)
Ms Melanie Young (CFO)
Company Secretary Ms Melanie Young
Principal Activities Developer of innovative treatments for cancer and diseases of the central nervous system.

BIONOMICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
17/04/2014   Bionomics NOW April 2014 Newsletter 4 PDF
07/04/2014   Bionomics to Feature at US Cancer Conference 2 PDF
28/03/2014   Appendix 3B 12 PDF
19/03/2014   BNC105 Results Presentation 27 PDF
19/03/2014   Webcast - BNC105 Phase II Renal Cancer Trial Results 2 PDF
19/03/2014 asterix BNC105 Phase II Renal Cancer Trial Results 5 PDF
17/03/2014 asterix Trading Halt 2 PDF
13/03/2014   Bionomics Wins Awards at Major BioPharma Asia Convention 2 PDF
10/03/2014   Bionomics CEO to Present at Roth Conference 2 PDF
07/03/2014 asterix S&P DJ Indices Announces March Quarterly Rebalance 10 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 0.450 -3.23% 0.470 0.450 119,820
16 Apr 2014 0.465 2.2% 0.485 0.460 231,933
15 Apr 2014 0.455 4.6% 0.457 0.445 61,262
14 Apr 2014 0.435 -10.31% 0.470 0.425 390,498
11 Apr 2014 0.485 -2.02% 0.510 0.460 249,279

* Volume of shares shown represents only those shares traded on ASX.

BIONOMICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BNO. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BNO

Warrants & Structured Products

No warrants & Structured Products are available over the security BNO

ASX CFDs

No Contracts For Differences are available over the security BNO